Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 May 1;16:2611–2623. doi: 10.2147/IDR.S402585

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 Zhang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

The performance of PAB, HIAPP, COSSH-ACLF II, CLIF-C ACLF and MELD for predicting the 30‐day mortality in the validation cohort (a) PAB level of non-survivor and survivor of HBV‐ACLF patients in the validation cohort. (b) HIAPP score of non-survivors and survivors in the validation cohort. (c) ROC analysis shows the performance of PAB, HIAPP, COSSH-ACLF II, CLIF-C ACLF, and MELD scores in the validation cohort.